Suze Orman Told You to Buy Spacex at $200, So Who is Telling You to Sell at $136?

Quick Read - Suze Orman's June 2026 advice to dollar-cost average into SPCX near $200 left followers underwater as the stock dropped to $136 and drew a fresh Sell initiation. - SpaceX posted a $541 million quarterly loss against $18.37 billion in capex, while a lockup expiration...</stron

Quick Read – Suze Orman’s June 2026 advice to dollar-cost average into SPCX near $200 left followers underwater as the stock dropped to $136 and drew a fresh Sell initiation. – SpaceX posted a $541 million quarterly loss against $18.37 billion in capex, while a lockup expiration…

leased 911 million new shares into the market. – Orman never specified a position-size cap, meaning a listener with 25% of a $500,000 portfolio in SPCX lost over $33,000 following identical advice. – On her June 18, 2026 podcast, Suze Orman told listeners that if they wanted exposure to Elon Musk’s newly public rocket company, the cleanest way was to dollar cost average into the stock itself, symbol SPCX, at around $200. That day, SpaceX (NASDAQ:SPCX) closed at $185

This morning it changed hands near $136, and an analyst desk flagged a fresh Sell initiation on the name, one of several bearish calls now on the Street. If you followed Orman’s advice and put $500 a month into SPCX starting June 18, you are underwater on nearly every tranche. Orman’s core audience is retirees and near-retirees who trust her voice on capital preservation.

A single-stock DCA into a pre-profit, capex-heavy IPO is a different animal than what most of that audience signed up for. Why This Advice Was Structurally Wrong for the Audience Dollar cost averaging reduces timing risk in a diversified portfolio. It is a poor tool for reducing valuation risk in a single stock.

Leave a Reply

Your email address will not be published. Required fields are marked *